(19)

(11)

EP 0 821 591 A1

(12)

(43) Date of publication: 04.02.1998 Bulletin 1998/06 (21) Application number: 96912910.0 (22) Date of filing: 19.04.1996

(51) International Patent Classification (IPC):  A01K 67/ 027( . ) A61K 38/ 00( . ) A61K 39/ 395( . ) A61P 25/ 00( . ) C07K 14/ 705( . ) C07K 16/ 28( . ) C12N 15/ 09( . ) C12P 21/ 08( . ) G01N 33/ 15( . ) A61K 35/ 74( . ) A61K 38/ 16( . ) A61K 48/ 00( . ) A61P 43/ 00( . ) C07K 16/ 18( . ) C12N 5/ 10( . ) C12N 15/ 12( . ) C12Q 1/ 02( . ) G01N 33/ 50( . ) (86) International application number: PCT/US1996/005434 (87) International publication number: WO 1996/032959 (24.10.1996 Gazette 1996/47)

(84) Designated Contracting States: AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE Designated Extension States: AL LT LV SI (30) Priority: 19.04.1995 US 19950424995 07.06.1995 US 19950483959 (71) Applicant: Acorda Therapeutics New York, NY 10019 (US)	(72) Inventor: SCHACHNER, Melitta CH-8006 Zurich (CH) (74) Representative: Denmark, James  Bailey, Walsh & Co. 5 York Place Leeds LS1 2SD Yorkshire Leeds LS1 2SD Yorkshire (GB)